Skip to main content
Observe Medical
AboutProductsBecome a DistributorInvestorsNewsNexusContact
Nexus

Talk to us about urine output monitoring in your ICU

Clinical questions, product evaluations and distributor enquiries - one contact form, routed to the right team.

Contact salesBecome a distributor
Observe Medical

Nordic medtech company advancing urine output monitoring in critical care - reducing infection risk and freeing clinical time in the ICU.

Follow us on LinkedIn

Products

  • UnoMeter™ Safeti Max
  • UnoMeter™ Safeti Plus
  • UnoMeter™ 500
  • UnoMeter™ Abdo‑Pressure
  • All products
  • Sippi®In development

Company

  • About us
  • Clinical evidence
  • News
  • Careers
  • Distributors
  • Procurement

Investors

  • Share information
  • Reports & presentations
  • Financial calendar
  • Stock exchange notices
  • Subscribe to releases
OBSRVListed on Euronext Expand Oslo

Contact

Headquarters

Observe Medical ASA

Dronning Eufemias gate 16

0191 Oslo, Norway

Sales & distributors

sales@observemedical.com

Orders & logistics

order@observemedical.com
Quality & regulatoryISO 13485 certifiedCE marked under EU MDR 2017/745

© 2026 Observe Medical ASA · All rights reserved.

Sippi®, UnoMeter™, UnoSafeCoat™, Safeti™, Abdo-Pressure™ and KombiKon™ are trademarks of Observe Medical ASA. This website is intended for healthcare professionals, procurement and distribution partners. Product availability and regulatory status vary by country; please contact your local distributor. Sippi® is in development and is not available for sale.

Observe Medical ASA - Euronext Expand Oslo: OBSRV

Investor relations

Observe Medical ASA is a Nordic medtech company commercialising the UnoMeter™ family and developing Sippi®, its digital successor. Listed on Euronext Expand Oslo under the ticker OBSRV.

NewsReports & presentationsProspectusFinancial calendarShare priceThe shareShareholdersGovernanceIR contact
News

Latest news

View news archive →

Press releases temporarily unavailable.

Reports & presentations+
Reports & presentations

Reports & presentations

Annual Reports+
2026+
  • Observe Medical-Annual Report 2025
2025+
  • Observe Medical-Annual Report 2024
2024+
  • Observe Medical-Annual Report 2023
2023+
  • Observe_Medical- ESEF file 2022-12-31-en
  • Observe_Medical- ESEF file 2022-12-31-en
Older+
  • Observe Medical-Annual Report 2021
  • Observe Medical – Annual Report 2020
  • Carve-out financial statements full year 2016-2018 Observe Medical Group
  • Observe Medical – Annual Report 2019
Interim Reports and Presentations+
2026+
  • 2026 Interim report, H1
  • 2025 Interim report, H2 & FY
2025+
  • 2024 Interim report, H2 & FY
  • 2025 Interim report, H1/2025
  • 2025 Trading update 7.10
2024+
  • 2024 first half year presentation
  • 2024 first half year report
2023+
  • Observe Medical Company presentation – June 2023
  • Observe Medical-Annual Report 2022
  • 2023 Q2 and first half year 2023 Report
  • 2023 second half and full year presentation (watch here)
  • 2023 second half and full year 2023 report
Older+
  • 2022 Q1 presentation (watch here)
  • 2022 Q1 report
  • 2022 Q2 and first half year – Presentation (watch here)
  • 2022 Q2 and first half year – Presentation
  • 2022 Q2 and first half year – Report
  • 2022 Q3 presentation (watch here)
  • 2022 Q3 Report
  • 2022 Q4 presentation (watch here)
  • 2022 Q4 report
  • 2021 Q1 presentation (watch here)
  • 2021 Q1 report
  • 2021 Q2 and first half year – Presentation (watch here)
  • 2021 Q2 and first half year – Presentation
  • 2021 Q2 and first half year – Report
  • 2021 Q3 presentation (watch here)
  • 2021 Q3 report
  • 2021 Q4 presentation (watch here)
  • 2021 Q4 report
  • 2020 Q1 presentation (watch here)
  • 2020 Q1 report
  • 2020 Q2 and first half year – Presentation (watch here)
  • 2020 Q2 and first half year – Presentation
  • 2020 Q2 and first half year – Report
  • 2020 Q3 presentation (watch here)
  • 2020 Q3 report
  • 2020 Q4 presentation (watch here)
  • 2020 Q4 report
  • 2019 Q4 presentation (watch here)
  • 2019 Q4 report
Other Reports+
2025+
  • Company presentation June 11 2025
2023+
  • Observe Medical ASA – Company presentation March 2023
  • Transparency act
  • Observe Medical Company presentation – June 2023 (recorded)
  • Observe Medical ASA – Company presentation November 2023 (recorded)
  • Observe Medical ASA – Company presentation November 2023
Older+
  • Observe Medical ASA – Company Presentation January 2022
  • Observe Medical ASA – Company Presentation May 2021
  • Investor presentation
Prospectus+
Prospectus

Prospectus

Access to the Observe Medical prospectus is restricted in certain jurisdictions under applicable securities laws. Please confirm your country of residence before proceeding.

Access the prospectus →

Financial calendar+
Financial calendar

Financial calendar

27 February 2026Second Half and Full Year 2025 results
30 April 2026Annual Report 2025
29 May 2026Annual General Meeting
25 August 2026First Half Year 2026 Report
Share price+
Share price

The share

View on Euronext →

Follow the Observe Medical share (OBSRV) on Euronext Expand Oslo. The chart updates through the trading day; the table below shows basic share data.

OBSRV
0.85 NOK+0.15 (+21.43%)
1.3191.1110.9030.6940.486
2025-10-272026-10-26

Stock data is delayed 15 minutes. For reference only.

The share+
The share

The share

Follow the development of the Observe Medical share on Euronext Expand Oslo under the OBSRV ticker. Observe Medical ASA has been listed on Euronext Expand Oslo since 4 November 2019.

For all stock exchange releases, see Oslo Stock Exchange NewsWeb (OBSRV) →

Basic share data

Stock ExchangeEuronext Expand Oslo
TickerOBSRV
First day of listing4 November 2019
SectorHealthcare
Trading CurrencyNOK
ISINNO0013457952
Number of shares issued136,148,412
Nominal valueNOK 0.42
Shareholders+
Shareholders

Shareholders

As at 17 September 2026

Swipe to see all columns

#NameNumber of shares% of top 20% of totalCountry
1Songa Capital AS11 000 00012.99%8.08%Norway
2R Investment Company AS10 703 68412.64%7.86%Norway
3JPB AS7 500 0008.86%5.51%Norway
4King Kong Invest AS6 333 3337.48%4.65%Norway
5Jiangsu Hongxin Medical Technology Ltd.6 000 0007.08%4.41%China
6Bjørntvedt, Vegard5 985 0107.07%4.40%Norway
7Care Holding AS5 271 7266.22%3.87%Norway
8Eidco AS4 000 0004.72%2.94%Norway
9Ro, Lars3 575 0004.22%2.63%Norway
10Livermore Invest AS3 386 4394.00%2.49%Norway
11Glimt Invest AS3 187 7133.76%2.34%Norway
12Em Kapital AS2 800 0003.31%2.06%Norway
13Songa X AS2 100 0002.48%1.54%Norway
14Agmably AS2 100 0002.48%1.54%Norway
15AKB AS2 100 0002.48%1.54%Norway
16F2 Funds AS2 012 4542.38%1.48%Norway
17Ginny Invest AS1 800 0002.13%1.32%Norway
18Bjørntvedt, Eivind1 650 0001.95%1.21%Norway
19Abk Villmarkshytta AS1 616 5691.91%1.19%Norway
20Thorsen1 572 7031.86%1.16%Norway
Total owned by top 2084 694 631100.00%62.21%
Total number of shares136 148 412
Total number of shareholders2 448
Governance+
Governance

Governance

Governance documents

General meeting+
2026+
  • 26 May 2023: Represented List
  • Notice of Annual General Meeting 29 May 2026
  • Minutes of the AGM 29 May 2026
Annual General Meeting - Documents+
  • Guidelines for determination of salary and other remuneration to executive personnel in Observe Medical ASA
  • Report of salary and other remuneration to leading personnel 2025
  • Board of Directors recommendation for appointment of Auditor
  • Nomination Committee Recommendation 2026
  • Annual accounts and the Annual report for 2025
  • Notice of the Annual General Meeting
2025+
  • App. 3. to the EGM notice_Independent expert report 3 July 2025
  • Notice of Extraordinary General Meeting 3 July 2025
  • Minutes of EGM 3 July 2025
  • Notice of Extraordinary General Meeting 10 October 2025
  • Minutes of EGM 10 October 2025
2024+
  • 3 May 2024: Observe Medical – Report of salary and other remuneration to leading personnel
  • 3 May 2024: Nomination Committee recommendation
  • 3 May 2024: Notice of Annual General Meeting on 24 May 2024, including attendance, advance vote, and proxy forms
  • 24 May 2024: Observe Medical ASA – Minutes from Annual General Meeting
  • 26 June 2024: Observe Medical ASA – Notice of Extraordinary General Meeting
  • 17 July 2024: Observe Medical ASA – Minutes from Extraordinary General Meeting
2023+
  • 5 May 2023: Nomination Committee recommendation
  • 5 May 2023: Notice of attendance and proxy form to the AGM on 26 May 2023
  • 5 May 2023:Notice of Annual General Meeting on 26 May 2023
  • 26 May 2023: Observe Medical ASA – Minutes from Annual General Meeting
  • 1 November 2023: Observe Medical ASA – Notice of Extraordinary General Meeting 22 November 2023
  • 22 November 2023: Observe Medical ASA – Minutes Extraordinary General Meeting
Older+
  • 5 August 2019: Extraordinary General Meeting
  • 1 October 2019: Extraordinary General Meeting
  • 24 October 2019: Extraordinary General Meeting
  • 26 May 2020: Notice of Extraordinary General Meeting on 16 June 2020
  • 9 June 2020: The Boards declaration on remuneration to executive management
  • 9 June 2020: Recommendation by the Nomination Committee
  • 9 June 2020: Attendance to the Annual General Meeting on 30 June 2020
  • 9 June 2020: Notice of Annual General Meeting on 30 June 2020
  • 16 June 2020: Extraordinary General Meeting
  • 30 June 2020: Annual General Meeting
  • 30 April 2021: Guidelines for determination of salary and other remuneration to executive Personnel
  • 30 April 2021: The Nomination Committee’s recommendation
  • 30 April 2021: Notice of attendance and proxy form to the Annual General meeting on 21 May 2021
  • 30 April 2021: Notice of Annual General Meeting on 21 May 2021
  • 21 May 2021: Minutes from Annual General meeting
  • 14 January 2022: Notice of Extraordinary General Meeting on 4 February 2022
  • 4 February 2022: Represented list
  • 4 February 2022: Minutes from Extraordinary General Meeting
  • 13 May 2022: Online guide LUMI (English)
  • 13 May 2022: Online guide LUMI (Norsk)
  • 13 May 2022: Report on salary and other remuneration to executive personnel year 2021
  • 13 May 2022: Guidelines for determination of salary and other remuneration to executive personnel
  • 13 May 2022: The Nomination Committee’s recommendation (part 1)
  • 13 May 2022: Notice of attendance and proxy form to the Annual General Meeting on 3 June 2022
  • 13 May 2022: Notice of Annual General Meeting on 3 June 2022
  • 31 May 2022: The Nomination Committee recommendation part 2
  • 31 May 2022: Board of Directors recommendation for appointment of auditor
  • 3 June 2022: Represented list
  • 3 June 2022: Minutes from Annual General Meeting 2022
Articles of association+
  • Observe Medical ASA – Articles of association per 13. October 2025
Corporate Governance Principles+
  • Corporate Governance Principles
Instructions for the Nomination Committee+

The Articles of Association provide for a nomination committee composed of two or three members. The current members are Bård Brath Ingerø (chair) and Kathrine Gamborg Andreassen. The committee nominates candidates for shareholder-elected members and the chairperson of the Board of Directors, nominates members to the nomination committee, and recommends remuneration.

Contact: Bård Brath Ingerø, Chair - +47 92 83 33 34 · bbi@reitenco.no

  • Instructions for the Nomination Committee
Transparency Act+
  • Transparency Act Statement
IR contact+
IR contact

IR contact

Jørgen Mann

Chief Executive Officer

+45 40 86 75 58
jorgen.mann@observemedical.com

Johan M. Fagerli

Chief Financial Officer

+47 95 81 27 65
johan.fagerli@observemedical.com

Sign up for the IR mailing list

Edit with